AI-Based Mobile Intervention on Medication Non-Adherence and Transition
Recruiting
Who can join
Ages 14 to 24 · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnosed with epilepsy * Currently prescribed anti-seizure medicine (ASMs) * Identified as part of an underserved population, defined as meeting at least one of the following: member of a racial or ethnic group historically underrepresented in research or healthcare or low-income status (e.g., eligible for public assistance or government-subsidized health coverage) * Are between 14-17 years old and able to provide assent, with a parent or LAR present to receive app notifications throughout the study * Are between 18-24 years old and able to provide informed consent * Able to read, speak, and write in English * Resides in Florida * Receive outpatient medical services Exclusion Criteria: * They do not own a mobile device with internet access. * They have a history of severe intellectual disability. * They are unable to operate a mobile device (keyboard or touchscreen). * Reside in an in-patient setting. * Adults unable to consent. * Pregnant women (excluded because pregnancy is not relevant to the study focus). * Prisoners.
About the study
This study aims to examine whether the AI-personalized version of the Medilepsy® app is more effective than the non-AI (standard version without AI personalization) can improve key outcomes, such as medical adherence and transition readiness, among underserved adolescents and young adults with epilepsy, ages 14-24, in Florida, USA.
Outcomes are organized into primary (effectiveness), secondary (usability), and exploratory (language experience) endpoints.
What is being tested
- Medilepsy® Chatbot AI-Enhanced (other)
- Medilepsy® Chatbot Standard (other)
Sponsor: University of Central Florida · Participants: 200 · Started: 2026-05
Contact the study team
- Michelle Tall, PhD, RN, FAES · Phone: 4077970555
- Amoy Fraser, PhD, CCRP, PMP · Phone: 4072668742
Official record on ClinicalTrials.gov — NCT07445074
Locations in the U.S.
| Florida | Orlando Health Arnold Palmer Hospital, Orlando Orlando Health Orlando Regional Medical Center, Orlando |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.